Rate My Professor Edmund Lau

Lau's research specializations include pulmonary vascular disease, pulmonary hypertension, difficult-to-treat airways disease, interstitial lung disease, and lung cancer screening and nodule assessment. He has produced over 100 peer-reviewed publications, demonstrating substantial impact in pulmonary circulation, advanced heart failure, chronic thromboembolic pulmonary hypertension, and related areas. Key publications encompass 'Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock' (Circulation: Heart Failure, 2025), 'Lung transplantation for chronic thromboembolic pulmonary hypertension' (Journal of Heart and Lung Transplantation, 2025), 'Long-term mortality in patients with chronic obstructive pulmonary disease and severe hypoxaemia' (Respirology, 2024), 'Pulmonary Hypertension by Catheterization Is More Accurately Predicted by Non-Invasively Derived Pulmonary Vascular Resistance Than Pulmonary Vascular Impedance' (JACC: Cardiovascular Imaging, 2023), and 'β3 adrenergic agonism: A novel pathway which improves right ventricular function in pulmonary hypertension' (Physiological Reports, 2023). Since 2016, he has directed the Pulmonary Hypertension Registry of Australia and New Zealand, significantly contributing to improved Pharmaceutical Benefits Scheme access for pulmonary hypertension therapies. Lau also occupies leadership roles as Deputy Chair of the Medical Council at Royal Prince Alfred Hospital and Treasurer of the Thoracic Society of Australia and New Zealand (New South Wales Branch), enhancing clinical standards and research collaboration in respiratory medicine.